Delivery Order SPE2DB25D2204-SPE2DB25FTGYA
- Not listed
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $27,721.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $16,561.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 20, 2025, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,831.93 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a $11,848.45 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $80,070.90 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by September 3, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a delivery order valued at $10,683.21 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pens on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical supply needs. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGYADelivery Order
The Defense Logistics Agency awarded a $12,870.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Defense Logistics Agency contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal healthcare needs. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supplier to deliver a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's substantial federal contract portfolio demonstrates its capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 8/26/25 |